References
- Center for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:400–2.
- World Health Organization. World now at the start of 2009 influenza pandemic: statement to the press by WHO Director-General Dr Margaret Chan. Geneva: WHO; 2009. Available at: http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html (accessed 28 June 2011).
- Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010;51:1184–91.
- Lin Y, Liu T, Wang S, Ren Y, Li Z, Wang X. Seroepidemiologic survey for antibody of the inapparent infection of pandemic influenza A(H1N1) in Shandong Province (In Chinese). Prev Med Trib 2010;16:293–4.
- Liu T, Lin Y, Zhang S, Wang S, Ren Y, Li Z, et al. Analysis on serum antibody level to pandemic influenza A (H1N1) virus in some population in Shandong Province (In Chinese). Disease Surveillance 2011;26:136–8.
- Xu C, Bai T, Iuliano AD, Wang M, Yang L, Wen L, et al. The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One 2010;6:e17919.
- Achonu C, Rosella L, Gubbay JB, Deeks S, Rebbapragada A, Mazzulli T, et al. Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009–May 2010. PLoS One 2011;6:e26427.
- Tian LL, Shi WX, Ying D, Pang XH, Peng Y, Fang H, et al. Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China. Preventive Medicine 2011;52:71–4.
- Šubelj V, Prosenc K, Sočan M. Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia. Wien Klin Wochenschr 2012;124:177–80.
- Zhang X, He J, Li L, Zhu X, Ke C, Ni H, et al. Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study. PLoS One 2010; 6:e23034.
- Cox CM, Goodin K, Fisher E, Dawood FS, Hamilton JJ, Leparc GF, et al. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida: November–December, 2009. PLoS One 2011;6:e29301.
- Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003;55:83–91.
- Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009;361:2619–27.
- Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school–New York City, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:470–2.
- National Center for Immunization and Respiratory Diseases, CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58:1–8.
- Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross sectional serological study. Lancet 2010;375:1100–8.
- Maltezou HC, Katerelos P, Mavrouli M, Lourida A, Routsias JG, Spanakis N, et al. Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece. Vaccine 2011;29:6664–9.
- France AM, Jackson M, Schrag S, Lynch M, Zimmerman C, Biggerstaff M, et al. Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April–May 2009. J Infect Dis 2010;201: 984–92.
- Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics—implications for policy. N Engl J Med 2009;360:2595–8.
- Chowell G, Bettencourt LM, Johnson N, Alonso WJ, Viboud C. The 1918–1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc Biol Sci 2008;275:501–9.
- Onozuka D, Hagihara A. Spatial and temporal dynamics of influenza outbreaks. Epidemiology 2008;19:824–8.
- Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, et al. Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J Hosp Infect 2011;78:308–11.
- Maltezou HC, Dedoukou X, Patrinos S, Maragos A, Poufta S, Gargalianos P, et al. Determinants of intention to get vaccinated against novel (pandemic) influenza A H1N1 among health-care workers in a nationwide survey. J Infect 2010;61:252–8.
- Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009;361:2414–23.
- Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010;375:56–66.